Envista Holdings Corporation

Equities

NVST

US29415F1049

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-17 pm EDT 5-day change 1st Jan Change
19.59 USD -0.96% Intraday chart for Envista Holdings Corporation -2.59% -18.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Envista Holdings Names Paul Keel as CEO MT
Envista Holdings Corporation Announces Chief Executive Officer Changes CI
Envista Holdings Corporation Announces Management Changes CI
Bausch + Lomb to Present New Data and Analyses at American Society of Cataract and Refractive Surgery Annual Meeting MT
Envista Holdings Starts CEO Succession Process MT
Leerink Partners Initiates Envista Holdings at Underperform Rating With $19 Price Target MT
North American Morning Briefing : Stock Futures -2- DJ
UBS Adjusts Envista Holdings Price Target to $23 From $26, Maintains Neutral Rating MT
Jefferies Downgrades Envista Holdings to Hold From Buy, Adjusts Price Target to $23 From $30 MT
North American Morning Briefing : Stock Futures -2- DJ
William Blair Downgrades Envista Holdings to Market Perform From Outperform MT
Sector Update: Health Care Stocks Steady Premarket Thursday MT
Envista Holdings' Q4 Adjusted Earnings Fall, Revenue Rises; Shares Fall Pre-Bell MT
Transcript : Envista Holdings Corporation, Q4 2023 Earnings Call, Feb 07, 2024
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q4 Revenue $645.6M, vs. Street Est of $638.4M MT
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q4 EPS $0.29, vs. Street Est of $0.34 MT
Envista Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Envista Holdings Corporation Provides Earnings Guidance for the Full Year 2024 CI
Envista Holdings Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Transcript : Envista Holdings Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:00 PM
General Motors US Deliveries Rise 14% in 2023, Led by Electric Vehicle Demand MT
Envista Holdings Corporation Appoints Three New Members to Leadership Team CI
Needham Starts Envista With Hold Rating MT
Transcript : Envista Holdings Corporation Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-16-2023 11:00 AM
Envista Holdings Insider Bought Shares Worth $215,253, According to a Recent SEC Filing MT
Chart Envista Holdings Corporation
More charts
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
19.59 USD
Average target price
24.27 USD
Spread / Average Target
+23.90%
Consensus
  1. Stock Market
  2. Equities
  3. NVST Stock
  4. News Envista Holdings Corporation
  5. Envista : Piper Sandler Adjusts Envista Holdings' Price Target to $45 From $41, Maintains Neutral Rating